Tyra Biosciences shareholders approve officer exculpation amendment to charter

Tyra Biosciences, Inc.

Amendment eliminates personal liability of officers for monetary damages for breach of fiduciary duty under Delaware law.
Three Class III directors elected: Melissa McCracken, Jake Simson, Rehan Verjee.
Ratification of Ernst & Young as independent auditor for fiscal year ending December 31, 2024.
Amendment effective upon filing with Delaware Secretary of State on May 29, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.